| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |